Ekaterina Galanzha
Concepts (257)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Flow Cytometry | 33 | 2019 | 546 | 5.040 |
Why?
| Neoplastic Cells, Circulating | 18 | 2020 | 93 | 4.670 |
Why?
| Photoacoustic Techniques | 20 | 2019 | 86 | 4.400 |
Why?
| Molecular Imaging | 13 | 2016 | 60 | 2.500 |
Why?
| Nanoparticles | 13 | 2019 | 173 | 1.890 |
Why?
| Acoustics | 8 | 2016 | 38 | 1.880 |
Why?
| Light | 9 | 2017 | 82 | 1.580 |
Why?
| Temperature | 7 | 2016 | 177 | 1.420 |
Why?
| Single-Cell Analysis | 3 | 2019 | 56 | 1.330 |
Why?
| Magnetite Nanoparticles | 4 | 2019 | 25 | 1.270 |
Why?
| Mesentery | 8 | 2011 | 36 | 1.220 |
Why?
| Gold | 14 | 2019 | 164 | 1.210 |
Why?
| Lasers | 15 | 2017 | 141 | 1.020 |
Why?
| Mice | 32 | 2019 | 6413 | 1.010 |
Why?
| Animals | 48 | 2019 | 14385 | 0.980 |
Why?
| Mice, Nude | 16 | 2018 | 283 | 0.960 |
Why?
| Luminescent Proteins | 2 | 2014 | 66 | 0.950 |
Why?
| Lymphatic Vessels | 5 | 2019 | 47 | 0.930 |
Why?
| Cell Line, Tumor | 18 | 2019 | 1550 | 0.840 |
Why?
| Lymphatic System | 2 | 2018 | 15 | 0.740 |
Why?
| Lymph | 5 | 2019 | 19 | 0.720 |
Why?
| Quantum Dots | 3 | 2017 | 18 | 0.720 |
Why?
| Sentinel Lymph Node Biopsy | 1 | 2020 | 127 | 0.710 |
Why?
| Metal Nanoparticles | 7 | 2017 | 96 | 0.700 |
Why?
| Meningeal Neoplasms | 1 | 2019 | 50 | 0.680 |
Why?
| Contrast Media | 9 | 2017 | 221 | 0.680 |
Why?
| Melanoma | 3 | 2019 | 313 | 0.680 |
Why?
| Nanotechnology | 4 | 2015 | 39 | 0.670 |
Why?
| Therapeutics | 1 | 2018 | 6 | 0.670 |
Why?
| Diagnostic Techniques and Procedures | 1 | 2018 | 6 | 0.670 |
Why?
| Optics and Photonics | 1 | 2018 | 13 | 0.660 |
Why?
| Nanotubes, Carbon | 11 | 2011 | 70 | 0.620 |
Why?
| Silicon Dioxide | 1 | 2017 | 18 | 0.610 |
Why?
| Neoplastic Stem Cells | 3 | 2020 | 103 | 0.610 |
Why?
| Fluorescent Dyes | 7 | 2019 | 116 | 0.590 |
Why?
| Melanoma, Experimental | 3 | 2016 | 49 | 0.580 |
Why?
| Rats | 15 | 2019 | 3415 | 0.580 |
Why?
| Cardiovascular Diseases | 2 | 2012 | 476 | 0.560 |
Why?
| Brain Neoplasms | 1 | 2019 | 284 | 0.550 |
Why?
| Lymphatic Metastasis | 4 | 2020 | 256 | 0.550 |
Why?
| Neoplasms | 10 | 2019 | 1316 | 0.530 |
Why?
| Microscopy, Fluorescence | 6 | 2012 | 198 | 0.520 |
Why?
| Anemia, Sickle Cell | 2 | 2016 | 94 | 0.500 |
Why?
| Microscopy | 4 | 2018 | 66 | 0.500 |
Why?
| Cell Tracking | 1 | 2014 | 5 | 0.500 |
Why?
| Blood Coagulation | 2 | 2011 | 69 | 0.470 |
Why?
| Magnetics | 3 | 2011 | 44 | 0.470 |
Why?
| Hemorheology | 3 | 2011 | 14 | 0.460 |
Why?
| Cerebrospinal Fluid | 1 | 2013 | 35 | 0.460 |
Why?
| Erythrocytes | 4 | 2016 | 98 | 0.440 |
Why?
| Phototherapy | 5 | 2019 | 53 | 0.440 |
Why?
| Blood Circulation | 2 | 2009 | 20 | 0.440 |
Why?
| Melanins | 4 | 2012 | 30 | 0.440 |
Why?
| Carotenoids | 1 | 2012 | 46 | 0.420 |
Why?
| Laser Therapy | 2 | 2009 | 91 | 0.420 |
Why?
| Bacteremia | 1 | 2012 | 101 | 0.400 |
Why?
| Humans | 34 | 2020 | 54284 | 0.400 |
Why?
| Leukocytes | 2 | 2016 | 85 | 0.400 |
Why?
| Image Cytometry | 4 | 2011 | 15 | 0.390 |
Why?
| Thromboembolism | 1 | 2011 | 56 | 0.390 |
Why?
| Bacteria | 1 | 2013 | 258 | 0.390 |
Why?
| Laser Scanning Cytometry | 3 | 2010 | 10 | 0.390 |
Why?
| Neoplasm Metastasis | 2 | 2015 | 252 | 0.370 |
Why?
| Skin Neoplasms | 3 | 2011 | 532 | 0.360 |
Why?
| Models, Animal | 3 | 2010 | 255 | 0.360 |
Why?
| Lasers, Semiconductor | 1 | 2009 | 10 | 0.360 |
Why?
| Cell Separation | 5 | 2008 | 107 | 0.360 |
Why?
| Image Interpretation, Computer-Assisted | 4 | 2007 | 119 | 0.350 |
Why?
| Hot Temperature | 6 | 2013 | 199 | 0.350 |
Why?
| Early Detection of Cancer | 2 | 2016 | 162 | 0.350 |
Why?
| Staphylococcal Infections | 1 | 2012 | 300 | 0.340 |
Why?
| Microscopy, Acoustic | 1 | 2008 | 6 | 0.340 |
Why?
| Nanotubes | 3 | 2019 | 38 | 0.330 |
Why?
| Spectrum Analysis | 7 | 2013 | 79 | 0.320 |
Why?
| Breast Neoplasms | 5 | 2018 | 1248 | 0.310 |
Why?
| Myocardial Infarction | 1 | 2011 | 427 | 0.300 |
Why?
| Blood Vessels | 2 | 2018 | 78 | 0.300 |
Why?
| Fluorescence | 4 | 2018 | 53 | 0.290 |
Why?
| Drug Evaluation, Preclinical | 1 | 2007 | 158 | 0.280 |
Why?
| Drug Delivery Systems | 2 | 2019 | 151 | 0.280 |
Why?
| Stroke | 1 | 2011 | 526 | 0.270 |
Why?
| Neoplasm Recurrence, Local | 2 | 2020 | 644 | 0.270 |
Why?
| Nicotinic Agonists | 1 | 2005 | 60 | 0.270 |
Why?
| Nanospheres | 2 | 2017 | 11 | 0.270 |
Why?
| Spectrum Analysis, Raman | 4 | 2014 | 68 | 0.270 |
Why?
| Lymph Nodes | 3 | 2020 | 284 | 0.260 |
Why?
| Microscopy, Electron, Transmission | 4 | 2017 | 87 | 0.260 |
Why?
| Blood Cells | 4 | 2012 | 58 | 0.260 |
Why?
| Early Diagnosis | 4 | 2016 | 96 | 0.260 |
Why?
| Green Fluorescent Proteins | 3 | 2019 | 110 | 0.250 |
Why?
| Antibodies | 4 | 2014 | 178 | 0.240 |
Why?
| Nicotine | 1 | 2005 | 207 | 0.240 |
Why?
| Color | 3 | 2016 | 29 | 0.240 |
Why?
| Photochemical Processes | 2 | 2014 | 10 | 0.240 |
Why?
| Hyperthermia, Induced | 2 | 2019 | 107 | 0.230 |
Why?
| Microscopy, Confocal | 2 | 2015 | 110 | 0.230 |
Why?
| Folic Acid | 2 | 2017 | 139 | 0.230 |
Why?
| Thermography | 3 | 2009 | 16 | 0.220 |
Why?
| Cell Count | 2 | 2019 | 181 | 0.210 |
Why?
| Rats, Sprague-Dawley | 5 | 2019 | 1663 | 0.210 |
Why?
| Plant Leaves | 2 | 2011 | 49 | 0.200 |
Why?
| Mice, Transgenic | 2 | 2016 | 656 | 0.200 |
Why?
| Staining and Labeling | 2 | 2013 | 106 | 0.200 |
Why?
| Cell Survival | 3 | 2018 | 657 | 0.190 |
Why?
| Photometry | 4 | 2010 | 17 | 0.180 |
Why?
| Protein Engineering | 1 | 2019 | 21 | 0.180 |
Why?
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 12 | 0.180 |
Why?
| Disease Models, Animal | 3 | 2016 | 1639 | 0.180 |
Why?
| Muscle Cells | 1 | 2019 | 24 | 0.180 |
Why?
| Nanocomposites | 1 | 2019 | 11 | 0.170 |
Why?
| Muscle Contraction | 1 | 2019 | 109 | 0.170 |
Why?
| Signal Processing, Computer-Assisted | 2 | 2011 | 92 | 0.170 |
Why?
| Doxorubicin | 1 | 2019 | 259 | 0.160 |
Why?
| Drug Carriers | 2 | 2015 | 81 | 0.150 |
Why?
| Lymphatic Abnormalities | 1 | 2017 | 22 | 0.150 |
Why?
| Optical Phenomena | 2 | 2017 | 11 | 0.150 |
Why?
| Materials Testing | 1 | 2017 | 62 | 0.150 |
Why?
| Molecular Probes | 1 | 2016 | 13 | 0.150 |
Why?
| Biocompatible Materials | 1 | 2017 | 65 | 0.150 |
Why?
| Image Enhancement | 2 | 2006 | 56 | 0.140 |
Why?
| Hemeproteins | 1 | 2016 | 5 | 0.140 |
Why?
| Parasitemia | 1 | 2016 | 5 | 0.140 |
Why?
| Microscopy, Video | 2 | 2006 | 18 | 0.140 |
Why?
| Embolism | 1 | 2016 | 27 | 0.140 |
Why?
| Transducers | 1 | 2016 | 20 | 0.140 |
Why?
| Staphylococcus aureus | 2 | 2012 | 361 | 0.140 |
Why?
| Ultrasonics | 1 | 2016 | 32 | 0.140 |
Why?
| Exosomes | 1 | 2016 | 45 | 0.140 |
Why?
| Plasmodium yoelii | 1 | 2016 | 17 | 0.140 |
Why?
| Malaria | 1 | 2016 | 37 | 0.140 |
Why?
| Reproducibility of Results | 3 | 2016 | 1304 | 0.130 |
Why?
| Escherichia coli | 2 | 2007 | 250 | 0.130 |
Why?
| Ultrasonography | 2 | 2007 | 480 | 0.130 |
Why?
| Image Processing, Computer-Assisted | 3 | 2018 | 256 | 0.130 |
Why?
| Pharmaceutical Preparations | 1 | 2015 | 86 | 0.120 |
Why?
| Plant Roots | 2 | 2011 | 37 | 0.120 |
Why?
| Apoptosis | 2 | 2018 | 1300 | 0.120 |
Why?
| Magnetic Phenomena | 1 | 2013 | 7 | 0.120 |
Why?
| Diagnostic Imaging | 2 | 2017 | 184 | 0.120 |
Why?
| Silver | 1 | 2014 | 54 | 0.120 |
Why?
| Particle Size | 1 | 2013 | 88 | 0.120 |
Why?
| Mosquito Control | 1 | 2013 | 4 | 0.110 |
Why?
| Aedes | 1 | 2013 | 9 | 0.110 |
Why?
| Mammary Neoplasms, Animal | 1 | 2013 | 38 | 0.110 |
Why?
| Staphylococcal Protein A | 1 | 2012 | 7 | 0.110 |
Why?
| Lipoproteins | 1 | 2012 | 45 | 0.110 |
Why?
| Complementary Therapies | 1 | 2012 | 31 | 0.110 |
Why?
| Antineoplastic Agents | 2 | 2013 | 1300 | 0.110 |
Why?
| Receptors, Cell Surface | 2 | 2009 | 130 | 0.110 |
Why?
| Erythrocyte Deformability | 1 | 2011 | 2 | 0.100 |
Why?
| Blood Viscosity | 1 | 2011 | 4 | 0.100 |
Why?
| Erythrocyte Aggregation | 1 | 2011 | 4 | 0.100 |
Why?
| Systems Integration | 3 | 2007 | 23 | 0.100 |
Why?
| Xylem | 1 | 2011 | 4 | 0.100 |
Why?
| Phloem | 1 | 2011 | 4 | 0.100 |
Why?
| Succinimides | 1 | 2011 | 8 | 0.100 |
Why?
| Fluoresceins | 1 | 2011 | 16 | 0.100 |
Why?
| Hematocrit | 1 | 2011 | 51 | 0.100 |
Why?
| Splanchnic Circulation | 1 | 2011 | 43 | 0.100 |
Why?
| Tumor Cells, Cultured | 2 | 2009 | 477 | 0.100 |
Why?
| Blood Volume | 1 | 2011 | 69 | 0.100 |
Why?
| Carotid Arteries | 1 | 2011 | 82 | 0.100 |
Why?
| Platelet Aggregation | 1 | 2011 | 82 | 0.100 |
Why?
| KB Cells | 1 | 2010 | 5 | 0.100 |
Why?
| Hemoglobins | 1 | 2011 | 126 | 0.100 |
Why?
| Cytochromes c | 1 | 2010 | 41 | 0.100 |
Why?
| Gene Expression Regulation, Plant | 1 | 2010 | 50 | 0.100 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2013 | 434 | 0.100 |
Why?
| Folate Receptors, GPI-Anchored | 1 | 2009 | 7 | 0.090 |
Why?
| Rheology | 1 | 2009 | 12 | 0.090 |
Why?
| Endothelium, Lymphatic | 2 | 2009 | 13 | 0.090 |
Why?
| Time Factors | 3 | 2018 | 3213 | 0.090 |
Why?
| Ablation Techniques | 1 | 2009 | 25 | 0.090 |
Why?
| Lymphography | 1 | 2009 | 9 | 0.090 |
Why?
| Etoposide | 1 | 2009 | 85 | 0.090 |
Why?
| Molecular Mimicry | 1 | 2009 | 64 | 0.090 |
Why?
| Spectrophotometry, Infrared | 1 | 2009 | 9 | 0.090 |
Why?
| Blood Chemical Analysis | 1 | 2009 | 34 | 0.090 |
Why?
| Adipocytes | 1 | 2010 | 129 | 0.090 |
Why?
| Blood Platelets | 1 | 2011 | 269 | 0.090 |
Why?
| Cell Death | 1 | 2009 | 223 | 0.080 |
Why?
| Neoplasms, Experimental | 1 | 2008 | 115 | 0.080 |
Why?
| Refractometry | 1 | 2007 | 7 | 0.080 |
Why?
| Blood Coagulation Tests | 1 | 2007 | 23 | 0.080 |
Why?
| Carrier Proteins | 1 | 2009 | 359 | 0.080 |
Why?
| Colony Count, Microbial | 1 | 2007 | 66 | 0.080 |
Why?
| Escherichia coli Infections | 1 | 2007 | 33 | 0.080 |
Why?
| Flow Injection Analysis | 1 | 2006 | 2 | 0.070 |
Why?
| Mitochondria | 1 | 2010 | 489 | 0.070 |
Why?
| Mesenteric Arteries | 1 | 2006 | 45 | 0.070 |
Why?
| Indocyanine Green | 2 | 2019 | 39 | 0.070 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 866 | 0.070 |
Why?
| Rats, Inbred F344 | 1 | 2005 | 209 | 0.070 |
Why?
| Cell Culture Techniques | 1 | 2005 | 112 | 0.060 |
Why?
| Microcirculation | 1 | 2005 | 89 | 0.060 |
Why?
| Sensitivity and Specificity | 3 | 2014 | 923 | 0.060 |
Why?
| Infrared Rays | 2 | 2016 | 27 | 0.060 |
Why?
| Spectrophotometry | 2 | 2016 | 36 | 0.060 |
Why?
| Female | 3 | 2018 | 28441 | 0.050 |
Why?
| Equipment Design | 3 | 2007 | 318 | 0.050 |
Why?
| Photochemistry | 2 | 2010 | 21 | 0.050 |
Why?
| Organ Culture Techniques | 1 | 2019 | 53 | 0.040 |
Why?
| Staurosporine | 1 | 2018 | 14 | 0.040 |
Why?
| Antibiotics, Antineoplastic | 1 | 2019 | 85 | 0.040 |
Why?
| Kinetics | 2 | 2011 | 692 | 0.040 |
Why?
| Computer Systems | 2 | 2009 | 21 | 0.040 |
Why?
| HeLa Cells | 2 | 2009 | 291 | 0.040 |
Why?
| Male | 4 | 2019 | 27334 | 0.040 |
Why?
| Nanomedicine | 1 | 2017 | 22 | 0.040 |
Why?
| Schizonts | 1 | 2016 | 4 | 0.040 |
Why?
| Ear | 1 | 2016 | 21 | 0.040 |
Why?
| Host-Parasite Interactions | 1 | 2016 | 20 | 0.040 |
Why?
| Equipment Failure Analysis | 2 | 2006 | 49 | 0.040 |
Why?
| Computers, Handheld | 1 | 2016 | 27 | 0.040 |
Why?
| Genes, Reporter | 1 | 2016 | 98 | 0.030 |
Why?
| Drug Compounding | 1 | 2015 | 28 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 1 | 2019 | 1476 | 0.030 |
Why?
| Workflow | 1 | 2015 | 57 | 0.030 |
Why?
| Mammography | 1 | 2015 | 95 | 0.030 |
Why?
| Biological Transport | 1 | 2015 | 195 | 0.030 |
Why?
| Surface Plasmon Resonance | 1 | 2014 | 25 | 0.030 |
Why?
| MCF-7 Cells | 1 | 2014 | 79 | 0.030 |
Why?
| Neoplasm Staging | 1 | 2016 | 806 | 0.030 |
Why?
| Biopsy | 1 | 2015 | 692 | 0.030 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2013 | 204 | 0.030 |
Why?
| Cells, Cultured | 2 | 2007 | 1737 | 0.030 |
Why?
| Intracellular Space | 1 | 2012 | 31 | 0.030 |
Why?
| Radiation Dosage | 1 | 2013 | 170 | 0.030 |
Why?
| Gentian Violet | 1 | 2011 | 6 | 0.030 |
Why?
| Optical Fibers | 1 | 2011 | 10 | 0.030 |
Why?
| Trypan Blue | 1 | 2011 | 10 | 0.030 |
Why?
| Hematologic Tests | 1 | 2011 | 11 | 0.030 |
Why?
| Methylene Blue | 1 | 2011 | 12 | 0.030 |
Why?
| Injections, Intravenous | 1 | 2011 | 148 | 0.030 |
Why?
| Aquaporin 2 | 1 | 2010 | 7 | 0.020 |
Why?
| Blood Loss, Surgical | 1 | 2011 | 79 | 0.020 |
Why?
| Immunoconjugates | 1 | 2011 | 38 | 0.020 |
Why?
| Cell Line | 1 | 2014 | 1153 | 0.020 |
Why?
| Caenorhabditis elegans | 1 | 2012 | 146 | 0.020 |
Why?
| Imaging, Three-Dimensional | 1 | 2012 | 171 | 0.020 |
Why?
| Neoplasm Transplantation | 1 | 2010 | 94 | 0.020 |
Why?
| Microarray Analysis | 1 | 2010 | 84 | 0.020 |
Why?
| Chylomicrons | 1 | 2010 | 4 | 0.020 |
Why?
| Oscillometry | 1 | 2010 | 9 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 2016 | 1999 | 0.020 |
Why?
| Neovascularization, Pathologic | 1 | 2011 | 168 | 0.020 |
Why?
| Plant Oils | 1 | 2010 | 18 | 0.020 |
Why?
| Survival Rate | 1 | 2013 | 951 | 0.020 |
Why?
| Phantoms, Imaging | 1 | 2010 | 126 | 0.020 |
Why?
| Drug Synergism | 1 | 2009 | 171 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2010 | 531 | 0.020 |
Why?
| Scattering, Radiation | 1 | 2007 | 31 | 0.020 |
Why?
| Blood Flow Velocity | 1 | 2006 | 114 | 0.020 |
Why?
| Oxidative Stress | 1 | 2012 | 958 | 0.020 |
Why?
| Algorithms | 1 | 2010 | 697 | 0.020 |
Why?
| Video Recording | 1 | 2005 | 90 | 0.020 |
Why?
| Treatment Outcome | 1 | 2009 | 5604 | 0.010 |
Why?
|
|
Galanzha's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|